serplulimab、bevacizumab
CHOICE IV
Phase 3 small_molecule active
Quick answer
serplulimab、bevacizumab for Rectal Cancer is a Phase 3 program (small_molecule) at Changhai Hospital with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Changhai Hospital
- Indication
- Rectal Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active